Nano-X Imaging Ltd. (NNOX) Earnings Call Transcripts

Nano-X Imaging Ltd.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of 2025, Nano-X Imaging Ltd. (NNOX:US) reported a revenue of $3.7 million, up 23% year-over-year, driven by growth in teleradiology services and the consolidation of Nano-X Health IT. However, the company faced a GAAP net loss of $33.4 million, significantly impacted by a $17.5 million impairment related to restructuring efforts. Management maintained guidance for 2026 revenue at $35 million, signaling confidence in future growth despite current operational challenges.

Reported metrics

Guidance from management

Management maintained revenue guidance for 2026 at $35 million, indicating confidence in achieving this target despite current operational challenges.

What management said

Besides the impairment expenses we recorded in 2025, which was the impairment of mainly whatever is related to the chip line in [ the ] fab which was amounted to $17.5 million in the noncash expense, we do anticipate relatively minor expenses which are related to more efficiency that we're going to enact. It won't be -- we don't anticipate that will be a significant amount of dollar. So that's actually going probably...

Bear in mind that this fab was built during COVID when semiconductors were not necessarily available. So right now, we are rationalizing the situation where we have a sustainable supplier with a much lower cost of being chips that we do. The Southern Korea go, we converted to more of R&D center for the ceramic teams that we are developing there and might be even another product which is going to come out from this re...

What analysts pressed on

Analysts expressed concerns regarding the pace of deployment and the impact of external regulatory processes on revenue generation. There were questions about the anticipated timing of revenue ramp-up and the implications of the restructuring on future financial performance.

Main topics on the call

• Revenue Growth — Nano-X reported a revenue of $3.7 million for Q4 2025, a 23% increase from $3.0 million in Q4 2024. Management noted, 'The increase in the company's revenue and gross profit from the teleradiology services was mainly att...
• Impairment and Restructuring — The company recorded a GAAP net loss of $33.4 million, primarily due to a $17.5 million impairment of long-lived assets. This restructuring is intended to align manufacturing activities with long-term financial goals, as...
• Commercial Agreements — Management highlighted new agreements that could lead to the deployment of 360 Nanox.ARC systems over the next 2-3 years, indicating a shift towards a CapEx model. 'This represents a fundamental shift in how we are poise...
• Future Guidance — Management maintained revenue guidance for 2026 at $35 million, with expectations for a ramp-up in the second half of the year. CFO Ran Daniel noted, 'I think that you will see most of the -- in the second half -- toward...

Read the full Nano-X Imaging Ltd. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 31 Nano-X Imaging Ltd. earnings call transcripts on record, spanning September 14, 2020 to June 25, 2026. Based on this history, Nano-X Imaging Ltd. reports quarterly. The most recent call on file is dated June 25, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

NNOX

Exchange

NasdaqGM

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

31

First call

September 14, 2020

Most recent

June 25, 2026

Reporting cadence

quarterly